BSE filing, NSE: BRAWN. Summary written from the filing by ALFA Finder's alert engine.
Brawn Biotech Ltd: key numbers
- Share price
- ₹25.75
- Market cap
- ₹7.73 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 9.0×Sector 48.7×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →Brawn Biotech Board Meeting Date
Brawn Biotech intimated a board meeting on 05 Nov 2026 to consider un-audited Q2 FY27 results. The trading window stays closed till 16 Nov 2026.
Brawn Biotech Other Announcement
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd held its 41st Annual General Meeting on September 29, 2026. All resolutions were passed by the shareholders with the requisite majority.
Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd has filed the notice for its 41st Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Brawn Biotech Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY
Brawn Biotech Ltd reported revenue from operations of ₹6.1 Cr (+5.2% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · +0.0% YoY
Other other announcement announcements
All →Rexpro Enterprises Other Announcement
Rexpro Enterprises filed the Acuité monitoring agency report for H1 FY2026-27 on IPO proceeds. The report flags delayed utilisation and an unused inorganic-growth object past its March 2026 timeline.
Nakoda Group Of Industries Other Announcement
Nakoda Group filed its quarterly Reg 32 statement on fund use from the preferential issue of 87,00,000 convertible warrants. It reports no deviation or variation, with ₹6.09 Crore received as the 25% upfront payment.
Arman Financial Services Other Announcement
Arman Financial Services disclosed its quarterly shareholding pattern as of 30 September 2026. Promoter and public holdings are reported in the standard Regulation 31 format.
Muthoot Microfin Other Announcement
Muthoot Microfin filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 55.47%, with no transaction reported.
Hittco Tools Other Announcement
Hittco Tools filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing discloses promoter, public and category-wise holdings.
Global Health Other Announcement
Global Health Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine Regulation 31 compliance statement with no transaction or business event.